Navigation Links
Progress made in HIV vaccine development

Researchers have successfully tested two candidate vaccines that may eventually be used together to confer immunity against HIV infection. Their findings are published in the December 15 issue of The Journal of Infectious Diseases, now available online.

Barney S. Graham, MD, PhD, and colleagues from the National Institutes of Health IH Vaccine Research Center in Maryland, the Fred Hutchinson Cancer Research Center in Seattle, and GenVec Incorporated tested two possible HIV vaccines with the hope of producing an immune response in healthy, uninfected adults. One was a plasmid DNA-based vaccine expressing genes from three dominant HIV subtypes, and the second used recombinant adenovirus serotype 5 (rAd5) as a vector to deliver similar HIV strains.

"Both approaches operate by gene delivery of customized vaccine antigens that are produced by host cells to initiate an immune response. DNA is simple and does not have the problem of anti-vector immunity. However, DNA may be less potent than vector-based gene delivery strategies. Replication-defective rAd5 has the advantage of targeted, efficient gene delivery and high potency, but may be susceptible to anti-vector immunity," said Graham.

Both vaccines were tested in healthy uninfected adult volunteers. The DNA vaccine was found safe and well-tolerated. By week 12 following immunization, 97.5% of vaccinees experienced positive CD4 T cell responses and 40% experienced positive CD8 T cell responses.

The recombinant vector vaccine was also well-tolerated, but higher doses led to some adverse events such as pain and fever. By week 4 following immunization, 93.3% of vaccinees experienced positive CD4 T cell responses, and 60% experienced positive CD8 T cell responses.

"HIV-specific CD8 cell responses clear virus infected cells, and appear during the declining viremia following acute infection," explained Graham. "HIV-specific CD4 responses also peak early in infection; however
'"/>

Source:Infectious Diseases Society of America


Page: 1 2

Related biology news :

1. Bevacizumab Combined With Chemotherapy Improves Progression-Free Survival for Patients With Advanced Breast Cancer
2. AIDS Public Awareness Campaign Expands Following Report Of Rapidly Progressive HIV
3. Progress on HIV/AIDS significant but insufficient
4. Progress being made in exploring potential use of stem cells to treat heart disease
5. Progress toward artificial photosynthesis?
6. Research advances quest for HIV-1 vaccine
7. A much-needed shot in the arm for HIV vaccine development
8. Discovery of key proteins shape could lead to improved bacterial pneumonia vaccine
9. Gene vaccine for Alzheimers disease shows promising results
10. Influenza vaccine uses insect cells to speed development
11. Norovirus, AIDS vaccine and Hepatitis Virus
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Progress made HIV vaccine development

(Date:2/18/2015)... , Feb. 18, 2015  Cepheid (NASDAQ: CPHD ... the following conferences, and invited investors to participate via webcast. ... Boston, MA Tuesday, March 3, 2015 at 11.20 ... Orlando, FL Wednesday, March 4, 2015 ... To access the live webcasts for these events, please visit ...
(Date:2/12/2015)... 12, 2015   MedNet Solutions , a ... study management systems, has recently bolstered its ... iMedNet as the eClinical ... and healthcare consultants.  Building on the Program,s existing ... and numerous co-marketing opportunities), MedNet,s new and improved ...
(Date:2/11/2015)... February 11, 2015 ... "Access Control Market by Product (Cards and Readers, Biometrics, ... Defense, Government, Industrial, Healthcare, Education) and By Geography - Global ... MarketsandMarkets, the Access Control Market is expected ... at a CAGR of 10.6% between 2014 ...
Breaking Biology News(10 mins):Cepheid to Webcast Upcoming Financial Presentations 2MedNet Solutions Announces Key Enhancements To Its iMedNet Partner Program 2Access Control Market Worth $10.4 Billion by 2020 2Access Control Market Worth $10.4 Billion by 2020 3Access Control Market Worth $10.4 Billion by 2020 4
... existence of life in outer space may have a surprisingly ... Understanding how life evolved on Earth is important in obtaining ... find life and what it might be like, said George ... is finishing work on a three-year research grant from NASA's ...
... attracts developing sensory nerves up the spinal cord toward ... in the opposite direction, down the cord and away ... Chicago in the September 2005 issue of Nature Neuroscience ... restore function to people with paralyzing spinal cord injuries. ...
... computer simulation whose results have enhanced scientific understanding ... by the National Institutes of Health, appears in ... the National Academy of Sciences. , Previous research ... histone proteins and DNA--exhibits salt-dependent conformations. Specifically, chains ...
Cached Biology News:Evolution of life on Earth may hold key to finding life in outer space 2Evolution of life on Earth may hold key to finding life in outer space 3Gradient guides nerve growth down spinal cord 2Gradient guides nerve growth down spinal cord 3
(Date:3/5/2015)... and TORONTO , March 5, 2015 ... clinical-stage company developing new therapeutics and molecular diagnostics that ... William G. Rice , Ph.D., Chairman, President and ... Annual ROTH Conference on Tuesday, March 10 th ... Laguna Niguel, CA. Dr. Rice ...
(Date:3/5/2015)... Chardon, Ohio (PRWEB) March 05, 2015 ... and Gold Development Partner located in Northeast Ohio, today ... chosen e2b teknologies to support its upgrade to the ... As the largest independent group practice of its kind ... base and large volume of transactions, so efficiency and ...
(Date:3/4/2015)... -- In an article published and posted online today, ... review the clinical aspects of diseases caused by 5 ... article, "Clinical Management of Potential Bioterrorism-Related Conditions," was published ... New England Journal of Medicine . ... Tom Inglesby—review the clinical management of conditions resulting from ...
(Date:3/4/2015)... , Mar. 04, 2015 Research and ... the addition of Jain PharmaBiotech,s new report ... their offering. This report follows ... characteristic that can be objectively measured and evaluated ... processes as well as pharmacological responses to a ...
Breaking Biology Technology:Aptose Biosciences to Present at the 27th Annual ROTH Conference 2Aptose Biosciences to Present at the 27th Annual ROTH Conference 3Physician Group Practice Chooses e2b teknologies to Support Its Upgrade to Sage 100 ERP 2014 2Latest Clinical Information On Bioterrorism Threats 2Global Biomarkers Report 2014-2024 - Technologies, Markets and Companies 2Global Biomarkers Report 2014-2024 - Technologies, Markets and Companies 3
... to biological systems? Until now, says Prof. Ron Naaman ... both biologists and physicists have considered quantum systems and ... research he conducted together with scientists in Germany, which ... a biological molecule DNA can discern between ...
... Tiens Biotech Group (USA), Inc. (the "Company" or "Tiens", NYSE ... to the research, development, manufacturing, and marketing of nutrition supplement ... announced financial results for the year ended December 31, 2010. ... $62.0 million for 2009.   Net income for ...
... SHANGHAI, March 31, 2011 /PRNewswire-Asia-FirstCall/ -- China-Biotics, Inc. (Nasdaq: ... leading developer, manufacturer and distributor of probiotics products in ... product sales order from its newly signed U.S. customer. ... its first sales order, and formally entered into its ...
Cached Biology Technology:Biological molecules select their spin 2Tiens Biotech Group (USA) Reports 2010 Results 2Tiens Biotech Group (USA) Reports 2010 Results 3Tiens Biotech Group (USA) Reports 2010 Results 4Tiens Biotech Group (USA) Reports 2010 Results 5Tiens Biotech Group (USA) Reports 2010 Results 6Tiens Biotech Group (USA) Reports 2010 Results 7China-Biotics Receives First U.S. Sales Order 2China-Biotics Receives First U.S. Sales Order 3
Human PDGF R beta MAb (Clone # PR7212)...
Recombinant Mouse IL-23, CF...
Rabbit Serum New Zealand or California Origin...
Collected from 8-12 week old New Zealand or Californian rabbits. Aseptically collected and processed to minimize hemolytic activity. Pricing: $60/unit for 1 - 10 units...
Biology Products: